6533b828fe1ef96bd12894de
RESEARCH PRODUCT
Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura – haemolytic uraemic syndrome
D. CaramazzaG. QuintiniI. AbbeneL. Lo CocoA. MalatoR. Di TrapaniG. SacculloG. PizzoR. PalazzoloR. BaroneG. MazzolaS. RizzoP. RagoneseP. AridonV. AbbadessaS. Siragusasubject
AdultMaleSalvage TherapyAdolescentPurpura Thrombotic ThrombocytopenicADAMTS13 ProteinCase ReportMiddle AgedADAM ProteinsAntibodies Monoclonal Murine-DerivedTreatment OutcomeHumansImmunologic FactorsFemaleRituximabrefractory thrombotic thrombocytopenic purpurayear | journal | country | edition | language |
---|---|---|---|---|
2010-07-01 |